Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
Oscotec Inc.
Oscotec Inc.
OncoC4, Inc.
Eli Lilly and Company
Canadian Cancer Trials Group
AstraZeneca
SWOG Cancer Research Network
University of Michigan Rogel Cancer Center
Alliance for Clinical Trials in Oncology
National University Hospital, Singapore
University of Arizona
AmpliMed Corporation
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Emory University
GlaxoSmithKline